Patients who were treated with PASCOFLAIR

PASCOFLAIR Group (Verum)

Age, Customized

Sex/Gender, Customized

Region of Enrollment

Symptom was assessed in a Likert scale ranging from 0 "no symptoms at all" to 10 "very severe symptoms"

Change of Symptom Inner Restlessness (Pre - Post)

Change of Symptom Sleep Disturbance (Pre - Post)

Change of Symptom Exhaustion (Pre - Post)

Change of Symptom Fear (Pre - Post)

Change of Symptom Lack of Concentration (Pre - Post)

Change of Symptom Transpiration (Pre - Post)

Change of Symptom Nausea (Pre - Post)

Change of Symptom Trembling (Pre - Post)

Change of Symptom Palpation (Pre - Post)

The Benzodiazepine Dependence Questionnaire (BDEPQ) is a 30 item self report questionnaire designed to measure dependence on benzodiazepine tranquilisers, sedatives and hypnotics. Items cover all aspects of the dependence syndrome with the exception of withdrawal symptoms. Each item is rated on a four point likert scale referring to experiences in the last month.
BDEPQ score ranges from 0 (no dependence) to 85 (most severe dependence).

Change of BDEPQ (Benzodiazepine Dependence Questionnaire)

RS-13 is a 13 items self Report questionnaire measure the resilience, which applies a reliance scale ranging from 13 (lowest stress resistance) to 91 (highest stress resistance).

Change of RS-13 (Resilience Questionnaire) (Pre - Post)

EQ-5D™ is a standardised instrument for use as a measure of health Outcome The EQ-5D assesses five aspects of QoL: mobility, self-care, usual activity, pain/discomfort and anxiety/depression. An EQ-5D profile score of 0 points represents the worst QoL (death), while 1 point stands for full health. Data analysis was performed according to the EuroQol manual. The EQ-VAS ranges from 0 (worst QoL) to 100 (best QoL).

Change in EQ-5D (Health Questionnaire) Scores (Pre - Post)

VAS values (Quality of Life) range from 0 (very poor) to 100 (best possible state).

Change of EQ-5D VAS Scores (Pre - Post)

Assessment of tolerability using a 5 point scale (very good, good, satisfactory, bad, very bad)

Tolerability Assess Using a 5 Point Scale

Overall Study

Dr. Inga Trompetter and Jennifer Lebert

Nervous Restlessness

Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

Pascoe Pharmazeutische Praeparate GmbH

Institut für Empirische Gesundheitsökonomie, Prof. Dr. Dr.med. Reinhard Rychlik,Am Ziegelfeld 28,51399 Burscheid,Germany

passiflora loefgrenii

תגובות רגישות יתר

hypersensitivity

passiflora

passiflora loefgrenii/תגובות רגישות יתר

Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע